We have examined genomic sequences and mRNA species hybridizing to a cDNA clone of a yolk sac carcinoma chondroitin sulfate proteoglycan designated PG19. Genomic blot hybridizations with cDNAs covering the majority of the PG19 mRNA sequence revealed 15 to 17 gene fragments. Similar analysis with probes representing either the propeptide or the combined core protein COOH-terminal domain and 3' untranslated sequences revealed single genomic fragments indicating that a single gene codes for the PGl9 proteoglycan. Genomic blot analysis with cDNA sequences coding for the serine-glycine repeat of the core protein identified the same gene fragments observed with the entire PG19 cDNA, indicating that this coding region is homologous with sequences present in multiple genes. The same probes were also used to examine mRNA expression. In addition to the PG19 mRNA, several PG19-related mRNAs could be seen. These PG19-related mRNAs had homology with the serine-glycine coding sequence of the PG19 cDNA. These mRNAs may be coding for proteoglycans. The mRNA coding for PG19 appeared to be uniquely expressed in parietal yolk sac and mast cell lineages. The PG19 mRNA existed in different forms in parietal yolk sac and mast cell lines due to cell-type-specific differences in the length of the 5' untranslated sequences. These results indicate that expression of the PG19 proteoglycan gene is regulated both in terms of cell-type-specific transcription and selection of a transcriptional start site.Proteoglycans are protein glycoconjugates present in a variety of basement membranes (17,20,30), extracellular matrices (3,8,17,26,31), and cell membranes (21, 34). Functionally and structurally, little is known about proteoglycans beyond their glycoconjugate structure (17). It is likely, however, that the diversity of core proteins revealed by biochemical and immunological studies and, more recently, sequence analyses of cloned cDNAs (6, 6a, 12, 21a, 35) reflects functional diversity as well. As examples, one proteoglycan appears to represent a subpopulation of the transferrin receptor (14), and another is associated with the intracellular transport of class II histocompatibility antigen polypeptides (37). Other proteoglycans interact with the major extracellular matrix and basement membrane components such as fibronectin (29), vitronectin (42), collagen (21, 29), and laminin (36, 47) and in doing so may regulate the formation of extracellular matrices and the adhesion of cells to such matrices (10, 21). The modulation of cell adhesion in particular may be important for cell division and cell migration, especially in malignant cells (10, 34).We have been interested in the structure and expression of a chondroitin sulfate proteoglycan secreted by a yolk sac carcinoma cell line (27) because of its interaction with extracellular matrix proteins (7, 29) and its ability to inhibit yolk sac carcinoma cell adhesion to collagen and fibronectin (7). The amino acid sequence of the yolk sac carcinoma proteoglycan core protein precursor and its proces...